comprehensive -WSS

comprehensive

author：focus 2025-10-01 17:35:24 - browse：781

Medical personnel wearing gloves adjust IV bags displayed on a conveyor belt. -- health policy coverage from STAT — Civica Rx is considering a move into chemotherapies amid drug shortages. Adobe

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies.

Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018. Months later, the publicly traded group purchasing organization Premier created a subsidiary, ProvideGx, with the same aim.

Although shortages are not new, the number of drugs in short supply has grown steadily for about two years. Shortages also have become more difficult to predict and are affecting drugs that are more critical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Eli Lilly expects to double planned employment in Boston center

WSS

Senate committee scrutinizes Medicare Advantage brokers

For Medicare Advantage, Democrats want stronger protections around AI

HHS leader on health, climate change and biopharma emissions

Biden report: The neurospychology of memory and aging

Gilead might be held responsible for not developing a drug

The dental labor crisis is a moment of opportunity

hotspot

comprehensive

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

Pharmacists can make shortage drugs, but at what cost?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: How biotech is using artificial intelligence

Novavax promises a turnaround & Lilly roils the obesity market

Researchers explore possible ties between long Covid, menopause

The high cost of giving birth even with insurance

For Medicare Advantage, Democrats want stronger protections around AI

How to save PrEP access — and even expand it

Pharmacists can make shortage drugs, but at what cost?

leisure time

Readout LOUD podcast: How biotech is using artificial intelligence

Impact of Dobbs ruling felt at reproductive medicine meeting

Why did Pfizer dish out millions for a Super Bowl ad?

FDA struggles to regulate food additives, sometimes for decades

Senate committee scrutinizes Medicare Advantage brokers

A disappointing year of Humira biosimilars

hotspot

entertainment

focus

explore